Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice

BACKGROUND: Azilsartan, an angiotensin II type 1 (AT1) receptor blocker (ARB), has a higher affinity for and slower dissociation from AT1 receptors and shows stronger inverse agonism compared to other ARBs. Possible benefits of azilsartan in diabetic vascular dysfunction have not been established. M...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Matsumoto, Sachiko, Shimabukuro, Michio, Fukuda, Daiju, Soeki, Takeshi, Yamakawa, Ken, Masuzaki, Hiroaki, Sata, Masataka
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916073/
https://ncbi.nlm.nih.gov/pubmed/24485356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-13-30
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items